The following webcast contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in the webcast include statements regarding (i) expectations, plans and timelines for the launch of the IDEXX inVue DxTM Cellular Analyzer, its launch menu and estimated initial Economic Value of the platform, (ii) expectations, plans and timelines regarding potential future menu and category expansions and the potential increase in the Economic Value of the platform over time, (iii) expectations for placement and utilization of the IDEXX inVue Dx Cellular Analyzer and other premium instruments, (iv) anticipated capabilities, performance and functionality of the IDEXX inVue Dx Cellular Analyzer in the veterinary clinic setting, (v) expectations related to anticipated benefits of the IDEXX inVue Dx Cellular Analyzer for veterinary practices, including enhanced productivity, improved workflow and expanded insights, (vi) expectations regarding the benefits the IDEXX inVue Dx Cellular Analyzer may provide to the Company, including new customer additions, customer retention, increased utilization of our Companion Animal Group diagnostics and the ability to leverage the platform by introducing new menu additions over time and utilize collected data to gain proprietary insights and (vii) expectations, plans, timeline and anticipated benefits of the update of the IDEXX VetLab® Station. While we believe the forward-looking statements contained in this webcast are accurate, these forward-looking statements are based on management’s current expectations and beliefs, as well as a number of assumptions concerning future events, and are subject to risks, uncertainties and other factors that may cause actual results to differ materially from those expressed in, or implied by, the forward-looking statements. Those risks and uncertainties include, among other things, the emergence of a competing product or other technological advances that decrease the differentiated nature of the IDEXX inVue Dx platform, the failure of the IDEXX inVue Dx to successfully compete against currently available options as expected, unexpected manufacturing limitations, including as a result of our inability to source necessary components or raw materials or scale up manufacturing, the protection and defense of our intellectual property associated with the IDEXX inVue Dx Cellular Analyzer, the failure of the IDEXX inVue Dx Cellular Analyzer to perform and deliver the expected benefits to veterinary practices, our inability to successfully innovate and expand the menu for the IDEXX inVue Dx Cellular Analyzer and macroeconomic, geopolitical and veterinary practice industry conditions that could affect the willingness of veterinary practices to install a new point-of-care instrument and/or impact the utilization of any installed IDEXX inVue Dx Cellular Analyzers. The reports filed by the Company pursuant to United States securities laws also contain discussions of the risks, uncertainties and other factors that affect our business that you should carefully evaluate together with the forward-looking statements, particularly the matters described under the headings “Business,” “Risk Factors,” “Legal Proceedings,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Quantitative and Qualitative Disclosures About Market Risks,” in our most recent Annual Report on Form 10-K, as well as our most recent filings on Forms 10-Q and 8-K. You are advised to review the Company’s filings with the United States Securities and Exchange Commission (which are available from the SEC’s EDGAR database at www.sec.gov and via the Company’s website at www.idexx.com). No forward-looking statement can be guaranteed. You should not put undue reliance on any forward-looking statements, which speak only as of today’s date. The Company assumes no obligation, and expressly disclaims any obligation, to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.